TIAA CREF Investment Management LLC increased its stake in OraSure Technologies, Inc. (NASDAQ:OSUR) by 3.6% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 549,875 shares of the medical instruments supplier’s stock after buying an additional 18,994 shares during the period. TIAA CREF Investment Management LLC owned approximately 0.95% of OraSure Technologies worth $7,110,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the company. Dimensional Fund Advisors LP increased its stake in OraSure Technologies by 29.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,494,674 shares of the medical instruments supplier’s stock valued at $21,903,000 after buying an additional 569,993 shares in the last quarter. JPMorgan Chase & Co. increased its stake in shares of OraSure Technologies by 127.2% in the first quarter. JPMorgan Chase & Co. now owns 1,573,586 shares of the medical instruments supplier’s stock worth $20,347,000 after buying an additional 881,132 shares during the period. State Street Corp increased its stake in shares of OraSure Technologies by 6.3% in the fourth quarter. State Street Corp now owns 1,346,519 shares of the medical instruments supplier’s stock worth $11,823,000 after buying an additional 79,922 shares during the period. Norges Bank acquired a new stake in shares of OraSure Technologies during the fourth quarter worth about $9,786,000. Finally, Bank of New York Mellon Corp increased its stake in shares of OraSure Technologies by 107.4% in the first quarter. Bank of New York Mellon Corp now owns 816,172 shares of the medical instruments supplier’s stock worth $10,553,000 after buying an additional 422,645 shares during the period. Hedge funds and other institutional investors own 90.12% of the company’s stock.

Shares of OraSure Technologies, Inc. (NASDAQ OSUR) traded up 2.89% on Monday, hitting $21.20. The stock had a trading volume of 1,659,096 shares. The stock has a market cap of $1.24 billion, a PE ratio of 39.19 and a beta of 1.57. OraSure Technologies, Inc. has a 12 month low of $6.53 and a 12 month high of $21.59. The company has a 50 day moving average price of $17.28 and a 200-day moving average price of $13.51.

OraSure Technologies (NASDAQ:OSUR) last posted its quarterly earnings results on Wednesday, August 2nd. The medical instruments supplier reported $0.09 EPS for the quarter, topping the consensus estimate of $0.07 by $0.02. OraSure Technologies had a net margin of 22.29% and a return on equity of 15.64%. The company had revenue of $40.18 million during the quarter, compared to analysts’ expectations of $36.54 million. During the same quarter in the previous year, the business posted $0.07 EPS. The firm’s revenue was up 28.1% on a year-over-year basis. On average, equities research analysts anticipate that OraSure Technologies, Inc. will post $0.48 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “TIAA CREF Investment Management LLC Increases Position in OraSure Technologies, Inc. (NASDAQ:OSUR)” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another domain, it was stolen and republished in violation of United States & international copyright & trademark laws. The correct version of this story can be accessed at https://www.thecerbatgem.com/2017/08/07/tiaa-cref-investment-management-llc-has-7-11-million-stake-in-orasure-technologies-inc-nasdaqosur-updated-updated-updated.html.

A number of equities research analysts recently issued reports on OSUR shares. Stephens reiterated an “overweight” rating and issued a $19.00 price objective (up previously from $14.00) on shares of OraSure Technologies in a research report on Tuesday, July 11th. BidaskClub downgraded OraSure Technologies from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 24th. Zacks Investment Research upgraded OraSure Technologies from a “hold” rating to a “buy” rating and set a $18.00 price objective on the stock in a research report on Saturday, May 6th. Jefferies Group LLC increased their price objective on OraSure Technologies from $16.00 to $19.00 and gave the stock a “buy” rating in a research report on Wednesday, June 28th. Finally, Canaccord Genuity raised their price target on OraSure Technologies from $15.00 to $18.00 and gave the company a “buy” rating in a research report on Wednesday, June 28th. Two research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $15.46.

In other news, CEO Douglas A. Michels sold 290,495 shares of the company’s stock in a transaction on Tuesday, June 27th. The shares were sold at an average price of $16.75, for a total value of $4,865,791.25. Following the completion of the transaction, the chief executive officer now owns 894,012 shares in the company, valued at approximately $14,974,701. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Anthony Zezzo II sold 115,000 shares of the company’s stock in a transaction on Wednesday, May 10th. The shares were sold at an average price of $14.70, for a total transaction of $1,690,500.00. Following the completion of the transaction, the executive vice president now owns 260,410 shares of the company’s stock, valued at approximately $3,828,027. The disclosure for this sale can be found here. Insiders have sold a total of 704,979 shares of company stock valued at $11,031,816 in the last quarter. 7.80% of the stock is currently owned by company insiders.

About OraSure Technologies

OraSure Technologies, Inc (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.

Institutional Ownership by Quarter for OraSure Technologies (NASDAQ:OSUR)

Receive News & Stock Ratings for OraSure Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies Inc. and related stocks with our FREE daily email newsletter.